CHE RSI Chart
Last 7 days
-3.4%
Last 30 days
-8.1%
Last 90 days
0.6%
Trailing 12 Months
6.7%
Historical Charts for Stock Metrics
Year | Q1 | Q2 | Q3 | Q4 |
---|---|---|---|---|
2023 | 2.2B | 2.2B | 2.2B | 2.3B |
2022 | 2.1B | 2.1B | 2.1B | 2.1B |
2021 | 2.1B | 2.1B | 2.1B | 2.1B |
2020 | 2.0B | 2.0B | 2.1B | 2.1B |
2019 | 1.8B | 1.9B | 1.9B | 1.9B |
2018 | 1.7B | 1.7B | 1.8B | 1.8B |
2017 | 1.6B | 1.6B | 1.6B | 1.7B |
2016 | 1.6B | 1.6B | 1.6B | 1.6B |
2015 | 1.5B | 1.5B | 1.5B | 1.5B |
2014 | 1.4B | 1.4B | 1.4B | 1.5B |
2013 | 1.4B | 1.4B | 1.4B | 1.4B |
2012 | 1.4B | 1.4B | 1.4B | 1.4B |
2011 | 1.3B | 1.3B | 1.3B | 1.4B |
2010 | 1.2B | 1.2B | 1.2B | 1.3B |
2009 | 0 | 1.2B | 1.2B | 1.2B |
2008 | 0 | 0 | 0 | 1.1B |
Stocks Marked 'Very Cheap' by Grufity's Fair Value Model Have Outperformed Russell 2000 Index
Small Caps and Mid Caps are mostly overlooked by investors as all the focus goes to Magnificent 7. These stocks that are not part of the beauty contest require a deeper look. However, all large cap stocks were once small caps. Grufity's Fair Value model opens up this unverse as it separates high-performing, rewarding stocks from low-performing risky stocks. <b>Russell 2000 stocks that were marked 'Very Cheap' by the model doubled in three years while the index was flat.</b>
Returns of $10,000 invested in:
Very Cheap Stocks: $21,859
Russell 2000 Index: $10,334
Very Expensive Stocks: $8,224
Russell 2000 stocks considered 'Very Cheap' by the model greatly outperformed Russell 2000 index and the 'Very Expensive' bucket over past three years.
Datesorted ascending | Name | Buy/Sell | $ Value | Avg. Price | # Shares | Title |
---|---|---|---|---|---|---|
Mar 28, 2024 | lee spencer s | acquired | 1,385,670 | 106 | 13,000 | executive vice president |
Mar 28, 2024 | lee spencer s | sold (taxes) | -4,557,960 | 643 | -7,080 | executive vice president |
Mar 28, 2024 | lee spencer s | sold | -1,283,300 | 641 | -2,000 | executive vice president |
Mar 21, 2024 | witzeman michael d | sold | -1,704,320 | 643 | -2,650 | vp & chief financial officer |
Mar 20, 2024 | witzeman michael d | acquired | 1,074,290 | 413 | 2,600 | vp & chief financial officer |
Mar 20, 2024 | judkins brian c | acquired | 5,300,010 | 443 | 11,958 | vp and chief legal officer |
Mar 20, 2024 | witzeman michael d | sold (taxes) | -229,841 | 647 | -355 | vp & chief financial officer |
Mar 20, 2024 | judkins brian c | sold | -7,196,910 | 645 | -11,158 | vp and chief legal officer |
Mar 06, 2024 | hutton thomas c | acquired | 1,466,990 | 449 | 3,267 | vice president |
Mar 06, 2024 | hutton thomas c | sold (taxes) | -1,693,560 | 633 | -2,673 | vice president |
Which funds bought or sold CHE recently?
View All DetailsDatesorted ascending | Fund Name | Type | % Chg | $ Change | $ Held | % Portfolio |
---|---|---|---|---|---|---|
Apr 17, 2024 | NEW MEXICO EDUCATIONAL RETIREMENT BOARD | added | 10.00 | -82,000 | 1,672,000 | 0.06% |
Apr 17, 2024 | Hennion & Walsh Asset Management, Inc. | sold off | -100 | -262,553 | - | -% |
Apr 16, 2024 | TSFG, LLC | unchanged | - | 11,000 | 128,000 | 0.03% |
Apr 16, 2024 | Financial Management Professionals, Inc. | unchanged | - | - | 3,000 | -% |
Apr 16, 2024 | CAPITAL INSIGHT PARTNERS, LLC | added | 7.55 | 979,524 | 6,401,330 | 1.20% |
Apr 16, 2024 | Ausbil Investment Management Ltd | reduced | -4.93 | 23,199 | 581,051 | 0.29% |
Apr 16, 2024 | MCF Advisors LLC | unchanged | - | 28,590 | 320,965 | 0.03% |
Apr 16, 2024 | Thrive Wealth Management, LLC | new | - | 225,959 | 225,959 | 0.05% |
Apr 16, 2024 | HENGEHOLD CAPITAL MANAGEMENT LLC | unchanged | - | 50,947 | 571,960 | 0.06% |
Apr 16, 2024 | Berger Financial Group, Inc | reduced | -1.23 | 23,963 | 307,887 | 0.03% |
Unveiling Chemed Corp's Major ShareHolders
Date Filed | Name of Filer | Percent of Class | No. of Shares | Form Type | |
---|---|---|---|---|---|
Peers (Alternatives to Chemed Corp)
Name | Mkt Capsorted ascending | Revenue | Price %, 1M | Returns, 1Y | P/E | P/S | Rev 1-Yr | Inc 1-Yr |
---|---|---|---|---|---|---|---|---|
LARGE-CAP | ||||||||
UNH | 454.7B | 371.6B | 20.32 | 1.22 | ||||
CI | 102.0B | 195.3B | 18.98 | 0.52 | ||||
CVS | 87.3B | 357.8B | 10.46 | 0.24 | ||||
HCA | 78.5B | 65.0B | 14.98 | 1.21 | ||||
CNC | 39.5B | 154.0B | 14.6 | 0.26 | ||||
DVA | 11.1B | 12.1B | 15.99 | 0.91 | ||||
UHS | 10.6B | 14.3B | 14.83 | 0.75 | ||||
MID-CAP | ||||||||
CHE | 9.0B | 2.3B | 33.17 | 3.99 | ||||
ACHC | 6.5B | 2.9B | -299.48 | 2.22 | ||||
AMN | 2.1B | 3.8B | 10.12 | 0.56 | ||||
AMEH | 2.1B | 1.4B | 33.88 | 1.48 | ||||
SMALL-CAP | ||||||||
ADUS | 1.6B | 1.1B | 25.19 | 1.49 | ||||
BKD | 1.2B | 3.0B | -6.54 | 0.41 | ||||
BEAT | 55.0M | - | -3.76 | - | ||||
AMS | 18.4M | 21.3M | 34.56 | 0.86 |
Chemed Corp News
Income Statement (Quarterly) | ||||||||||||||||||||||
Description | (%) Q/Q | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 |
Revenue | 3.8% | 586 | 565 | 554 | 560 | 547 | 526 | 531 | 531 | 541 | 539 | 532 | 527 | 528 | 528 | 502 | 516 | 522 | 481 | 474 | 462 | 453 |
Costs and Expenses | -0.7% | 475 | 478 | 484 | 487 | 465 | 446 | 439 | 441 | 443 | 446 | 461 | 447 | 390 | 454 | 409 | 436 | 445 | 416 | 408 | 413 | 390 |
S&GA Expenses | 0.8% | 100 | 100 | 95.00 | 100 | 97.00 | 84.00 | 88.00 | 90.00 | 92.00 | 89.00 | 94.00 | 92.00 | 87.00 | 88.00 | 85.00 | 71.00 | 83.00 | 77.00 | 72.00 | 74.00 | 67.00 |
EBITDA Margin | 6.8% | 0.18* | 0.17* | 0.17* | 0.17* | 0.18* | 0.19* | 0.20* | 0.19* | 0.19* | 0.21* | 0.21* | 0.22* | 0.22* | 0.19* | 0.18* | 0.17* | 0.16* | 0.15* | 0.15* | - | - |
Interest Expenses | -23.0% | 0.00 | 0.00 | 1.00 | 2.00 | 2.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
Income Taxes | 39.5% | 26.00 | 18.00 | 17.00 | 17.00 | 20.00 | 20.00 | 20.00 | 21.00 | 22.00 | 23.00 | 19.00 | 18.00 | 32.00 | 14.00 | 18.00 | 13.00 | 14.00 | 8.00 | 14.00 | 6.00 | 8.00 |
Earnings Before Taxes | 23.9% | 116 | 93.00 | 70.00 | 71.00 | 82.00 | 76.00 | 86.00 | 85.00 | 96.00 | 95.00 | 75.00 | 84.00 | 146 | 82.00 | 100 | 69.00 | 80.00 | 67.00 | 64.00 | 51.00 | 63.00 |
EBT Margin | 8.5% | 0.15* | 0.14* | 0.14* | 0.15* | 0.15* | 0.16* | 0.17* | 0.16* | 0.16* | 0.19* | 0.18* | 0.20* | 0.19* | 0.16* | 0.16* | 0.14* | 0.13* | 0.13* | 0.13* | - | - |
Net Income | 20.1% | 90.00 | 75.00 | 53.00 | 54.00 | 62.00 | 57.00 | 66.00 | 64.00 | 75.00 | 72.00 | 57.00 | 65.00 | 114 | 68.00 | 82.00 | 56.00 | 66.00 | 59.00 | 51.00 | 45.00 | 54.00 |
Net Income Margin | 9.5% | 0.12* | 0.11* | 0.10* | 0.11* | 0.12* | 0.12* | 0.13* | 0.12* | 0.13* | 0.14* | 0.14* | 0.16* | 0.15* | 0.13* | 0.13* | 0.12* | 0.11* | 0.11* | 0.11* | - | - |
Free Cashflow | 460.4% | 97.00 | 17.00 | 116 | 43.00 | 82.00 | 39.00 | 44.00 | 88.00 | 49.00 | 102 | 9.00 | 89.00 | 71.00 | 114 | 176 | 69.00 | 50.00 | 117 | 21.00 | - | - |
Balance Sheet | ||||||||||||||||||||||
Description | (%) Q/Q | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 |
Assets | 6.8% | 1,668 | 1,562 | 1,505 | 1,431 | 1,442 | 1,356 | 1,313 | 1,306 | 1,343 | 1,318 | 1,384 | 1,458 | 1,435 | 1,367 | 1,291 | 1,278 | 1,268 | 1,233 | 1,094 | 1,070 | 976 |
Current Assets | 26.9% | 501 | 395 | 337 | 262 | 273 | 199 | 203 | 185 | 230 | 201 | 269 | 347 | 329 | 271 | 189 | 199 | 191 | 168 | 180 | 159 | 160 |
Cash Equivalents | 52.4% | 264 | 173 | 160 | 58.00 | 74.00 | 8.00 | 10.00 | 18.00 | 33.00 | 29.00 | 92.00 | 210 | 163 | 113 | 20.00 | 29.00 | 6.00 | 9.00 | 3.00 | 9.00 | 5.00 |
Inventory | -4.1% | 12.00 | 13.00 | 12.00 | 11.00 | 10.00 | 10.00 | 11.00 | 11.00 | 10.00 | 8.00 | 7.00 | 7.00 | 7.00 | 8.00 | 7.00 | 7.00 | 7.00 | 7.00 | 6.00 | 6.00 | 6.00 |
Net PPE | -0.8% | 204 | 205 | 208 | 204 | 200 | 194 | 192 | 192 | 194 | 191 | 193 | 190 | 188 | 181 | 183 | 184 | 176 | 173 | 150 | 165 | 162 |
Goodwill | 0.0% | 585 | 585 | 582 | 581 | 581 | 580 | 580 | 580 | 579 | 579 | 579 | 579 | 579 | 579 | 578 | 577 | 577 | 577 | 511 | 511 | 511 |
Liabilities | 3.2% | 560 | 543 | 553 | 551 | 643 | 635 | 628 | 639 | 719 | 538 | 513 | 529 | 534 | 566 | 540 | 594 | 542 | 560 | 476 | 482 | 384 |
Current Liabilities | 5.0% | 312 | 297 | 302 | 283 | 297 | 298 | 285 | 280 | 302 | 286 | 267 | 290 | 299 | 329 | 319 | 247 | 262 | 252 | 224 | 217 | 192 |
Long Term Debt | - | - | - | - | 16.00 | 93.00 | 96.00 | 112 | 120 | 185 | - | - | - | - | - | - | 160 | 90.00 | 130 | 85.00 | 100 | 89.00 |
LT Debt, Current | - | - | - | - | 5.00 | 5.00 | 5.00 | 5.00 | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
LT Debt, Non Current | - | - | - | - | 16.00 | 93.00 | 96.00 | 112 | 120 | 185 | - | - | - | - | - | - | 160 | 90.00 | 130 | 85.00 | 100 | 89.00 |
Shareholder's Equity | 8.7% | 1,108 | 1,019 | 952 | 880 | 799 | 721 | 685 | 667 | 623 | 780 | 871 | 929 | 901 | 801 | 751 | 684 | 727 | 672 | 619 | 588 | 591 |
Retained Earnings | 3.6% | 2,447 | 2,363 | 2,294 | 2,246 | 2,198 | 2,141 | 2,090 | 2,029 | 1,970 | 1,901 | 1,835 | 1,784 | 1,724 | 1,615 | 1,553 | 1,476 | 1,426 | 1,365 | 1,311 | 1,265 | 1,226 |
Additional Paid-In Capital | 6.9% | 1,341 | 1,254 | 1,240 | 1,186 | 1,150 | 1,100 | 1,089 | 1,064 | 1,044 | 1,008 | 1,000 | 983 | 961 | 925 | 904 | 879 | 861 | 842 | 817 | 804 | 774 |
Accumulated Depreciation | -100.0% | - | 348 | 342 | 338 | 336 | 338 | 330 | 326 | 318 | 311 | 307 | 299 | 293 | 289 | 281 | 279 | 270 | 264 | 259 | 254 | 248 |
Shares Outstanding | 0.1% | 15.00 | 15.00 | 15.00 | 15.00 | 15.00 | 15.00 | 15.00 | 15.00 | 16.00 | 16.00 | 16.00 | 16.00 | 16.00 | 16.00 | 16.00 | 16.00 | 16.00 | 16.00 | 16.00 | - | - |
Float | - | - | - | 8,050 | - | - | - | 6,872 | - | - | - | 7,332 | - | - | - | 7,056 | - | - | - | 5,635 | - | - |
Cashflow (Quarterly) | ||||||||||||||||||||||
Description | (%) Q/Q | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 |
Cashflow From Operations | 275.3% | 108,563 | 28,927 | 132,317 | 60,492 | 100,199 | 52,017 | 56,580 | 101,090 | 63,570 | 112,988 | 25,320 | 106,719 | 86,877 | 124,590 | 188,496 | 89,326 | 63,604 | 128,738 | 35,322 | 73,585 | 56,530 |
Cashflow From Investing | 24.4% | -11,670 | -15,438 | -16,521 | -17,013 | -19,488 | -14,279 | -11,687 | -13,948 | -14,045 | -10,410 | -15,879 | -17,423 | -15,962 | -10,220 | -13,885 | -21,493 | -13,098 | -149,213 | -14,515 | -13,934 | -56,276 |
Cashflow From Financing | -2213.7% | -6,085 | -263 | -13,926 | -59,551 | -14,366 | -39,597 | -53,413 | -101,877 | -45,373 | -165,955 | -127,477 | -41,815 | -21,005 | -21,981 | -183,186 | -45,040 | -53,414 | 26,218 | -26,252 | -55,714 | -62,882 |
Dividend Payments | 0.4% | 6,056 | 6,034 | 5,727 | 5,685 | 5,626 | 5,669 | 5,400 | 5,322 | 5,559 | 5,593 | 5,427 | 5,437 | 5,440 | 5,401 | 5,108 | 5,130 | 5,131 | 5,090 | 4,768 | 4,799 | 4,812 |
Buy Backs | 178.4% | 39,928 | 14,344 | - | - | 12,976 | 24,325 | 49,420 | 27,794 | 245,662 | 163,731 | 125,542 | 41,107 | 28,471 | 24,975 | 21,913 | 100,235 | 20,705 | - | 22,676 | 49,250 | 36,908 |
Consolidated Statements Of Income - USD ($) shares in Thousands, $ in Thousands | 12 Months Ended | ||
---|---|---|---|
Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021 | |
Consolidated Statements Of Income [Abstract] | |||
Service revenues and sales (Note 2) | $ 2,264,417 | $ 2,134,963 | $ 2,139,261 |
Cost of services provided and goods sold (excluding depreciation) | 1,465,602 | 1,369,877 | 1,369,458 |
Selling, general and administrative expenses | 395,120 | 358,727 | 366,727 |
Depreciation | 50,802 | 49,102 | 49,011 |
Amortization | 10,063 | 10,070 | 10,040 |
Other operating expenses (Note 20) | 2,261 | 3,691 | 987 |
Total costs and expenses | 1,923,848 | 1,791,467 | 1,796,223 |
Income from operations | 340,569 | 343,496 | 343,038 |
Interest expense | (3,108) | (4,584) | (1,868) |
Other income/(expense)--net (Note 10) | 12,906 | (9,233) | 9,144 |
Income before income taxes | 350,367 | 329,679 | 350,314 |
Income taxes (Note 11) | (77,858) | (80,055) | (81,764) |
Net income | $ 272,509 | $ 249,624 | $ 268,550 |
Earnings Per Share (Note 16) | |||
Net income | $ 18.11 | $ 16.72 | $ 17.14 |
Average number of shares outstanding | 15,050 | 14,929 | 15,671 |
Diluted Earnings Per Share (Note 16) | |||
Net income | $ 17.93 | $ 16.53 | $ 16.85 |
Average number of shares outstanding | 15,200 | 15,099 | 15,938 |
Consolidated Balance Sheets - USD ($) $ in Thousands | Dec. 31, 2023 | Dec. 31, 2022 |
---|---|---|
Current assets | ||
Cash and cash equivalents (Note 9) | $ 263,958 | $ 74,126 |
Accounts receivable | 181,511 | 139,408 |
Inventories | 12,004 | 10,272 |
Prepaid income taxes | 13,166 | 18,515 |
Prepaid expenses | 30,204 | 30,291 |
Total current assets | 500,843 | 272,612 |
Investments of deferred compensation plans held in trust (Notes 15 and 17) | 106,126 | 93,196 |
Properties and equipment, at cost, less accumulated depreciation (Note 13) | 203,840 | 199,714 |
Lease right of use asset (Note 14) | 126,387 | 135,662 |
Identifiable intangible assets less accumulated amortization (Note 6) | 90,264 | 99,726 |
Goodwill | 585,017 | 581,295 |
Other assets (Note 12) | 55,618 | 59,807 |
Total Assets | 1,668,095 | 1,442,012 |
Current liabilities | ||
Accounts payable | 64,034 | 41,884 |
Current portion of long-term debt (Note 3) | 5,000 | |
Income taxes (Note 11) | 6,858 | |
Accrued insurance | 58,568 | 58,515 |
Accrued compensation | 88,381 | 87,350 |
Accrued legal | 6,386 | 4,456 |
Short-term lease liability (Note 14) | 38,635 | 38,996 |
Other current liabilities (Note 21) | 49,188 | 61,004 |
Total current liabilities | 312,050 | 297,205 |
Deferred income taxes (Note 11) | 30,321 | 38,613 |
Long-term debt (Note 3) | 92,500 | |
Deferred compensation liabilities (Note 15) | 104,069 | 92,330 |
Long-term lease liability (Note 14) | 100,776 | 110,513 |
Other liabilities | 13,003 | 12,136 |
Total Liabilities | 560,219 | 643,297 |
Commitments and contingencies (Note 18) | ||
STOCKHOLDERS' EQUITY | ||
Capital stock - authorized 80,000,000 shares $1 par; issued 37,183,681 shares (2022 - 36,795,792 shares) | 37,184 | 36,796 |
Paid-in capital | 1,341,273 | 1,149,899 |
Retained earnings | 2,446,925 | 2,197,918 |
Treasury stock - 22,148,927 shares (2022 - 21,920,993 shares) | (2,719,588) | (2,588,145) |
Deferred compensation payable in Company stock (Note 15) | 2,082 | 2,247 |
Total Stockholders' Equity | 1,107,876 | 798,715 |
Total Liabilities and Stockholders' Equity | $ 1,668,095 | $ 1,442,012 |
 | Mr. Kevin J. McNamara |
---|---|
 | chemed.com |
 | Healthcare Plans |
 | 14167 |